arginine and efegatran

arginine has been researched along with efegatran in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (80.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Callas, DD; Fareed, J1
Callas, DD; Fareed, J; Hoppensteadt, D1
Andrade-Gordon, P; Costanzo, MJ; Hecker, LR; Kauffman, JA; Krishnan, R; Lewis, JM; Maryanoff, BE; Schott, MR; Tulinsky, A; Yabut, SC; Zhang, HC1
Kleiman, NS1
Verstraete, M1
Deinum, J; Elg, M; Gustafsson, D1
Naylor-Olsen, AM; Sanderson, PE1
Criscuoli, M; Di Bugno, C; Giorgi, R; Harmat, NJ; Lippi, A; Martinelli, A; Monti, S; Subissi, A1
Adams, TE; Everse, SJ; Mann, KG1

Reviews

4 review(s) available for arginine and efegatran

ArticleYear
Clinical trials of conjunctive anticoagulant strategies in thrombolysis.
    Coronary artery disease, 1996, Volume: 7, Issue:7

    Topics: Anticoagulants; Antithrombins; Arginine; Blood Platelets; Clinical Trials as Topic; Epoprostenol; Heparin; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Oligopeptides; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombin; Thrombolytic Therapy

1996
Modulating platelet function with selective thrombin inhibitors.
    Haemostasis, 1996, Volume: 26 Suppl 4

    Topics: Administration, Oral; Adult; Animals; Antithrombins; Arginine; Blood Platelets; Boron Compounds; Clinical Trials as Topic; Dogs; Drug Evaluation, Preclinical; Glycine; Hirudin Therapy; Hirudins; Humans; Naphthalenes; Oligopeptides; Peptide Fragments; Pipecolic Acids; Piperidines; Recombinant Proteins; Sulfonamides; Thrombin

1996
Thrombin inhibitor design.
    Current medicinal chemistry, 1998, Volume: 5, Issue:4

    Topics: Anticoagulants; Antithrombins; Arginine; Binding Sites; Dipeptides; Drug Design; Humans; Models, Molecular; Oligopeptides; Pipecolic Acids; Piperidines; Platelet Aggregation Inhibitors; Structure-Activity Relationship; Sulfonamides; Thrombin

1998
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
    Lancet (London, England), 2002, Jan-26, Volume: 359, Issue:9303

    Topics: Angina, Unstable; Antithrombins; Arginine; Glycine; Heparin; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Oligopeptides; Peptide Fragments; Pipecolic Acids; Piperidines; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Survival Rate; Thrombin

2002

Other Studies

6 other study(ies) available for arginine and efegatran

ArticleYear
Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy.
    Thrombosis research, 1995, Jun-01, Volume: 78, Issue:5

    Topics: Antifibrinolytic Agents; Antithrombin III; Antithrombins; Aprotinin; Arginine; Binding Sites; Boron Compounds; Enzyme Activation; Fibrinolysis; Heparin; Hirudins; Humans; Oligopeptides; Peptide Fragments; Pipecolic Acids; Protein C; Recombinant Proteins; Sulfonamides; Thrombin

1995
Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin.
    Seminars in thrombosis and hemostasis, 1995, Volume: 21, Issue:2

    Topics: Amino Acid Sequence; Anticoagulants; Antithrombins; Arginine; Endopeptidases; Feedback; Hirudins; Humans; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides

1995
Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl group.
    Journal of medicinal chemistry, 1996, Aug-02, Volume: 39, Issue:16

    Topics: Amino Acid Sequence; Animals; Arginine; Binding Sites; Cattle; Crystallography, X-Ray; Guanidines; Humans; Molecular Sequence Data; Molecular Structure; Oligopeptides; Peptides; Pipecolic Acids; Protein Binding; Serine Proteinase Inhibitors; Sulfonamides; Thiazoles; Thrombin; Trypsin Inhibitors

1996
The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
    Thrombosis and haemostasis, 1997, Volume: 78, Issue:4

    Topics: Amino Acid Chloromethyl Ketones; Animals; Anticoagulants; Arginine; Azetidines; Benzylamines; Carotid Artery Thrombosis; Dose-Response Relationship, Drug; Fibrinolytic Agents; Glycine; Hemodynamics; Heparin; Hirudin Therapy; Hirudins; Kinetics; Male; Oligopeptides; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Piperidines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sulfonamides; Thrombin; Thrombin Time

1997
1,2-disubstituted cyclohexane derived tripeptide aldehydes as novel selective thrombin inhibitors.
    Bioorganic & medicinal chemistry letters, 1998, May-19, Volume: 8, Issue:10

    Topics: Aldehydes; Amino Acid Sequence; Antithrombins; Arginine; Binding Sites; Cyclohexanes; Indicators and Reagents; Kinetics; Models, Molecular; Molecular Structure; Oligopeptides; Protein Conformation; Stereoisomerism; Structure-Activity Relationship; Thrombin

1998
Predicting the pharmacology of thrombin inhibitors.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:5

    Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Blood Coagulation; Computer Simulation; Dose-Response Relationship, Drug; Glycine; Hirudins; Humans; Kinetics; Models, Cardiovascular; Oligopeptides; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin

2003